Zoo Pharma Dynamics (ZPD) is an integrated biotechnology firm specializing in the synthesis, development, and optimization of novel veterinary therapeutics. By leveraging a multidisciplinary framework across pharmacology, molecular biology, and veterinary clinical science, we engineer advanced healthcare solutions that bridge the gap between animal and human physiological welfare.

Our operational model emphasizes a seamless transition from bench to stall. Through our strategic subsidiary, MAKA Bioscience, we translate complex research into scalable pharmaceutical applications.

​

Integrated Research & Infrastructure

Our capabilities are anchored by our South Texas Research Laboratory and Animal Facility. This co-located infrastructure allows for an iterative R&D cycle, where real-time pharmacokinetic and pharmacodynamic data directly inform our on-site manufacturing processes. By maintaining a closed-loop system between clinical observation and production, we maximize therapeutic efficacy and ensure rigorous quality control.

​

Collaborative Innovation

We operate on the principle that systemic health challenges require cross-functional synergy. ZPD actively engages in high-level partnerships with premier biotech entities to integrate emerging technologies into our pipeline. This collaborative approach allows us to address zoonotic trends and comparative medicine with high precision.

​

Ethical Standards & Animal Welfare

ZPD is committed to the 3Rs (Replacement, Reduction, and Refinement) in all research protocols. Our initiatives adhere to the highest ethical benchmarks, ensuring that our pursuit of medical advancement is conducted with absolute non-maleficence. We believe that pioneering science and rigorous animal welfare standards are mutually inclusive.

​

Through evidence-based research and precision manufacturing, Zoo Pharma Dynamics is establishing the technical vanguard for the future of global health.